← All trials
NCT04610541
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 12, 2020
- Primary completion
- Oct 30, 2021
- Completion date
- Nov 30, 2021
- First posted
- Oct 30, 2020
- Last posted
- Nov 27, 2020
- Enrollment
- 2000
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PecsLead sponsor
- HECRIN ConsortiumCollaborator
- Government of HungaryCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.